Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002762 · ClinicalTrials.gov registry record
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
A clinical trial of Breast Cancer and Perioperative/Postoperative Complications, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 1,118
- Enrollment target
- 20
- Study locations
NCT00002762 is a study of Breast Cancer and Perioperative/Postoperative Complications that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 1,118 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (60% lower). The trial reports 20 study locations across 14 states.
The verdict
NCT00002762, a study of Breast Cancer and Perioperative/Postoperative Complications, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 1,118 participants
- Enrollment target
- 20
- Study locations
Study Summary
RATIONALE: Timing of breast cancer surgery may improve effectiveness of treatment and may help patients live longer. PURPOSE: Clinical trial to determine whether timing of primary surgery in relation to menstrual cycle is associated with disease-free survival 5 years after surgery in women who have stage I or stage II breast cancer.
Conditions Studied
Interventions
- BEHAVIORAL patient interviewing to obtain menstrual history
- PROCEDURE blood sampling
Study Locations (20)
California
- Scripps Cancer Center at Scripps Clinic - La Jolla
- Rebecca and John Moores UCSD Cancer Center - La Jolla
Florida
- Baptist Regional Cancer Institute - Jacksonville - Jacksonville
- CCOP - Mount Sinai Medical Center - Miami Beach
Georgia
- Winship Cancer Institute of Emory University - Atlanta
- CCOP - Atlanta Regional - Atlanta
Illinois
- CCOP - Evanston - Evanston
- Rockford Clinic - Rockford
Maryland
- Franklin Square Hospital Center - Baltimore
- Warren Grant Magnuson Clinical Center - Bethesda
Massachusetts
- Cancer Research Center at Boston Medical Center - Boston
- Lahey Clinic Medical Center - Burlington - Burlington
Alabama
- MBCCOP - Gulf Coast - Mobile
Arizona
- CCOP - Western Regional, Arizona - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,118 participants |
| Start Date | 1996-06 |
| Est. Completion | 2009-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002762
The ClinicalTrials.gov registry entry for NCT00002762 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,118 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (60% lower). The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which patient interviewing to obtain menstrual history is the first listed.
NCT00002762 reports 20 study locations spanning 14 distinct geographic areas - top geographies include California, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT00002762 about?
NCT00002762 is a clinical study titled "Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer". RATIONALE: Timing of breast cancer surgery may improve effectiveness of treatment and may help patients live longer. PURPOSE: Clinical trial to determine whether timing of primary surgery in relation to menstrual cycle is associated with disease-free survival 5 years after surgery in women who have...
What is the current status of trial NCT00002762?
This trial is currently completed. The enrollment target is 1,118 participants. The study started on 1996-06. Estimated completion is 2009-10.
What conditions does trial NCT00002762 study?
This clinical trial studies the following conditions: Breast Cancer, Perioperative/Postoperative Complications.
What interventions are being tested in trial NCT00002762?
The interventions under investigation include: patient interviewing to obtain menstrual history (BEHAVIORAL), blood sampling (PROCEDURE).
Who is sponsoring clinical trial NCT00002762?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00002762 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.